Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012

Deborah L Christensen, Kim Van Naarden Braun, Jon Baio, Deborah Bilder, Jane Charles, John N Constantino, Julie Daniels, Maureen S Durkin, Robert T Fitzgerald, Margaret Kurzius-Spencer, Li-Ching Lee, Sydney Pettygrove, Cordelia Robinson, Eldon Schulz, Chris Wells, Martha S Wingate, Walter Zahorodny, Marshalyn Yeargin-Allsopp, Deborah L Christensen, Kim Van Naarden Braun, Jon Baio, Deborah Bilder, Jane Charles, John N Constantino, Julie Daniels, Maureen S Durkin, Robert T Fitzgerald, Margaret Kurzius-Spencer, Li-Ching Lee, Sydney Pettygrove, Cordelia Robinson, Eldon Schulz, Chris Wells, Martha S Wingate, Walter Zahorodny, Marshalyn Yeargin-Allsopp

Abstract

Problem/condition: Autism spectrum disorder (ASD).

Period covered: 2012.

Description of system: The Autism and Developmental Disabilities Monitoring (ADDM) Network is an active surveillance system that provides estimates of the prevalence and characteristics of ASD among children aged 8 years whose parents or guardians reside in 11 ADDM Network sites in the United States (Arkansas, Arizona, Colorado, Georgia, Maryland, Missouri, New Jersey, North Carolina, South Carolina, Utah, and Wisconsin). Surveillance to determine ASD case status is conducted in two phases. The first phase consists of screening and abstracting comprehensive evaluations performed by professional service providers in the community. Data sources identified for record review are categorized as either 1) education source type, including developmental evaluations to determine eligibility for special education services or 2) health care source type, including diagnostic and developmental evaluations. The second phase involves the review of all abstracted evaluations by trained clinicians to determine ASD surveillance case status. A child meets the surveillance case definition for ASD if one or more comprehensive evaluations of that child completed by a qualified professional describes behaviors that are consistent with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision diagnostic criteria for any of the following conditions: autistic disorder, pervasive developmental disorder-not otherwise specified (including atypical autism), or Asperger disorder. This report provides ASD prevalence estimates for children aged 8 years living in catchment areas of the ADDM Network sites in 2012, overall and stratified by sex, race/ethnicity, and the type of source records (education and health records versus health records only). In addition, this report describes the proportion of children with ASD with a score consistent with intellectual disability on a standardized intellectual ability test, the age at which the earliest known comprehensive evaluation was performed, the proportion of children with a previous ASD diagnosis, the specific type of ASD diagnosis, and any special education eligibility classification.

Results: For 2012, the combined estimated prevalence of ASD among the 11 ADDM Network sites was 14.5 per 1,000 (one in 69) children aged 8 years. Estimated prevalence was significantly higher among boys aged 8 years (23.4 per 1,000) than among girls aged 8 years (5.2 per 1,000). Estimated ASD prevalence was significantly higher among non-Hispanic white children aged 8 years (15.3 per 1,000) compared with non-Hispanic black children (13.1 per 1,000), and Hispanic (10.2 per 1,000) children aged 8 years. Estimated prevalence varied widely among the 11 ADDM Network sites, ranging from 8.2 per 1,000 children aged 8 years (in the area of the Maryland site where only health care records were reviewed) to 24.6 per 1,000 children aged 8 years (in New Jersey, where both education and health care records were reviewed). Estimated prevalence was higher in surveillance sites where education records and health records were reviewed compared with sites where health records only were reviewed (17.1 per 1,000 and 10.4 per 1,000 children aged 8 years, respectively; p<0.05). Among children identified with ASD by the ADDM Network, 82% had a previous ASD diagnosis or educational classification; this did not vary by sex or between non-Hispanic white and non-Hispanic black children. A lower percentage of Hispanic children (78%) had a previous ASD diagnosis or classification compared with non-Hispanic white children (82%) and with non-Hispanic black children (84%). The median age at earliest known comprehensive evaluation was 40 months, and 43% of children had received an earliest known comprehensive evaluation by age 36 months. The percentage of children with an earliest known comprehensive evaluation by age 36 months was similar for boys and girls, but was higher for non-Hispanic white children (45%) compared with non-Hispanic black children (40%) and Hispanic children (39%).

Interpretation: Overall estimated ASD prevalence was 14.5 per 1,000 children aged 8 years in the ADDM Network sites in 2012. The higher estimated prevalence among sites that reviewed both education and health records suggests the role of special education systems in providing comprehensive evaluations and services to children with developmental disabilities. Disparities by race/ethnicity in estimated ASD prevalence, particularly for Hispanic children, as well as disparities in the age of earliest comprehensive evaluation and presence of a previous ASD diagnosis or classification, suggest that access to treatment and services might be lacking or delayed for some children.

Public health action: The ADDM Network will continue to monitor the prevalence and characteristics of ASD among children aged 8 years living in selected sites across the United States. Recommendations from the ADDM Network include enhancing strategies to 1) lower the age of first evaluation of ASD by community providers in accordance with the Healthy People 2020 goal that children with ASD are evaluated by age 36 months and begin receiving community-based support and services by age 48 months; 2) reduce disparities by race/ethnicity in identified ASD prevalence, the age of first comprehensive evaluation, and presence of a previous ASD diagnosis or classification; and 3) assess the effect on ASD prevalence of the revised ASD diagnostic criteria published in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Figures

FIGURE 1
FIGURE 1
Estimated prevalence* of autism spectrum disorder among children aged 8 years — Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012 Abbreviations: ADDM = Autism and Developmental Disabilities Monitoring Network; E+H = education and health records; HO = health records only. *Cases per 1,000 children aged 8 years. Bars represent 95% confidence intervals.
FIGURE 2
FIGURE 2
Scores of most recent intelligence quotient tests for children identified with autism spectrum disorder for whom test data were available — Autism and Developmental Disabilities Monitoring Network, nine sites,* United States, 2012 Abbreviations: ADDM = Autism and Developmental Disabilities Monitoring Network; ASD = autism spectrum disorder; E+H = education and health records; IQ = intelligence quotient. *Includes sites having information on intellectual ability available for ≥70% of children who met the ASD case definition (N = 3,353, excluding unknown IQ).
FIGURE 3
FIGURE 3
Estimated prevalence* of autism spectrum disorder among children aged 8 years, by most recent intelligence quotient score and by site — Autism and Developmental Disabilities Monitoring Network, nine sites, United States, 2012 Abbreviations: ADDM = Autism and Developmental Disabilities Monitoring Network; ASD = autism spectrum disorder; E+H = education and health records; IQ = intelligence quotient. *Cases per 1,000 children aged 8 years. †Includes sites having information on intellectual ability available for ≥70% of children who met the ASD case definition (N = 4,189, including unknown IQ). Maryland source type is education and health records.
FIGURE 4
FIGURE 4
Estimated prevalence* of autism spectrum disorder among children aged 8 years, by most recent intelligence quotient score, by sex and race/ethnicity — Autism and Developmental Disabilities Monitoring Network, nine sites, United States, 2012 Abbreviation: IQ = intelligence quotient. *Cases per 1,000 children aged 8 years. †Includes nine sites (Arizona, Arkansas, Colorado, Georgia, Maryland [education and health records], New Jersey, North Carolina, South Carolina, and Utah) having information on intellectual ability available for ≥70% of children who met the ASD case definition (N = 4,189, including unknown IQ).
FIGURE 5
FIGURE 5
Percentage of children with autism spectrum disorder at age 8 years who had previous autism spectrum disorder classification on record, suspicion of the disorder noted, or no mention of the disorder, by site — Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012 Abbreviations: ADDM = Autism and Developmental Disabilities Monitoring Network; ASD = autism spectrum disorder.

References

    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
    1. Gillberg C, Wing L. Autism: not an extremely rare disorder. Acta Psychiatr Scand 1999;99:399–406. 10.1111/j.1600-0447.1999.tb00984.x
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
    1. Burd L, Fisher W, Kerbeshian J. A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry 1987;26:700–3. 10.1097/00004583-198709000-00014
    1. Ritvo ER, Freeman BJ, Pingree C, et al. The UCLA-University of Utah epidemiologic survey of autism: prevalence. Am J Psychiatry 1989;146:194–9. 10.1176/ajp.146.2.194
    1. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207–15. 10.1023/A:1015453830880
    1. Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics 2005;115:e277–82. 10.1542/peds.2004-1958
    1. California Department of Developmental Services. Autistic spectrum disorders: changes in the California caseload, an update: 1999 through 2002. Sacramento, CA: California Health and Human Services Agency, Department of Developmental Services; 2003.
    1. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Natl Health Stat Report 2013;65:1–11.
    1. Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics 2011;127:1034–42. 10.1542/peds.2010-2989
    1. Kogan MD, Blumberg SJ, Schieve LA, et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 2009;124:1395–403. 10.1542/peds.2009-1522
    1. Schieve LA, Rice C, Yeargin-Allsopp M, et al. Parent-reported prevalence of autism spectrum disorders in US-born children: an assessment of changes within birth cohorts from the 2003 to the 2007 National Survey of Children’s Health. Matern Child Health J 2012;16(Suppl 1):S151–7. 10.1007/s10995-012-1004-0
    1. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49–55. 10.1001/jama.289.1.49
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators. Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010. MMWR Surveill Summ 2014;63(No. SS-2).
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012;61(No. SS-3):1–19.
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009;58(No. SS-10):1–20.
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. MMWR Surveill Summ 2007;56(No. SS-1):12–28.
    1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2000. MMWR Surveill Summ 2007;56(No. SS-1):1–11.
    1. Johnson CP, Myers SM; American Academy of Pediatrics Council on Children with Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007;120:1183–215. 10.1542/peds.2007-2361
    1. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2010.
    1. Yeargin-Allsopp M, Murphy CC, Oakley GP, Sikes RK. A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study. Pediatrics 1992;89:624–30.
    1. US Department of Health and Human Services. Code of Federal Regulations. Title 45. Public Welfare CFR 46. Washington, DC: US Department of Health and Human Services; 2010.
    1. Blumberg SJ, Zablotsky B, Avila RM, Colpe LJ, Pringle BA, Kogan MD. Diagnosis lost: differences between children who had and who currently have an autism spectrum disorder diagnosis. Autism 2015:1362361315607724–..
    1. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Study. Natl Health Stat Report 2015;87:1–20.
    1. Lai MC, Lombardo MV, Suckling J, et al.; MRC AIMS Consortium. Biological sex affects the neurobiology of autism. Brain 2013;136:2799–815. 10.1093/brain/awt216
    1. Werling DM, Geschwind DH. Understanding sex bias in autism spectrum disorder. Proc Natl Acad Sci U S A 2013;110:4868–9. 10.1073/pnas.1301602110
    1. Andersson GW, Gillberg C, Miniscalco C. Pre-school children with suspected autism spectrum disorders: do girls and boys have the same profiles? Res Dev Disabil 2013;34:413–22. 10.1016/j.ridd.2012.08.025
    1. Jarquin VG, Wiggins LD, Schieve LA, Van Naarden-Braun K. Racial disparities in community identification of autism spectrum disorders over time; Metropolitan Atlanta, Georgia, 2000–2006. J Dev Behav Pediatr 2011;32:179–87. 10.1097/DBP.0b013e31820b4260
    1. Flores G, Abreu M, Tomany-Korman SC. Why are Latinos the most uninsured racial/ethnic group of US children? A community-based study of risk factors for and consequences of being an uninsured Latino child. Pediatrics 2006;118:e730–40. 10.1542/peds.2005-2599
    1. Jo H, Schieve LA, Rice CE, et al. Age at autism spectrum disorder (ASD) diagnosis by race, ethnicity, and primary household language among children with special health care needs, United States, 2009–2010. Matern Child Health J 2015;19:1687–97. 10.1007/s10995-015-1683-4
    1. Zuckerman KE, Mattox K, Donelan K, Batbayar O, Baghaee A, Bethell C. Pediatrician identification of Latino children at risk for autism spectrum disorder. Pediatrics 2013;132:445–53. 10.1542/peds.2013-0383
    1. Zuckerman KE, Sinche B, Cobian M, et al. Conceptualization of autism in the Latino community and its relationship with early diagnosis. J Dev Behav Pediatr 2014;35:522–32. 10.1097/DBP.0000000000000091
    1. Zuckerman KE, Sinche B, Mejia A, Cobian M, Becker T, Nicolaidis C. Latino parents’ perspectives on barriers to autism diagnosis. Acad Pediatr 2014;14:301–8. 10.1016/j.acap.2013.12.004
    1. Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 2010;125:e17–23. 10.1542/peds.2009-0958
    1. Eapen V, Crnčec R, Walter A. Clinical outcomes of an early intervention program for preschool children with Autism Spectrum Disorder in a community group setting. BMC Pediatr 2013;13:3. 10.1186/1471-2431-13-3
    1. Reichow B, Barton EE, Boyd BA, Hume K. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012;10:CD009260.
    1. Rogers SJ, Estes A, Lord C, et al. Effects of a brief Early Start Denver model (ESDM)-based parent intervention on toddlers at risk for autism spectrum disorders: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2012;51:1052–65. 10.1016/j.jaac.2012.08.003
    1. Christensen DL, Bilder DA, Zahorodny W, et al. Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the Autism and Developmental Disabilities Monitoring Network. J Dev Behav Pediatr 2016;37:1–8. 10.1097/DBP.0000000000000235
    1. Nonkin Avchen R, Wiggins LD, Devine O, et al. Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders. J Autism Dev Disord 2011;41:227–36. 10.1007/s10803-010-1050-7
    1. Lazarus C, Autry A, Baio J, Avchen RN, Van Naarden Braun K. Impact of postcensal versus intercensal population estimates on prevalence of selected developmental disabilities—metropolitan Atlanta, Georgia, 1991–1996. Am J Ment Retard 2007;112:462–6. 10.1352/0895-8017(2007)112[462:IOPVIP];2
    1. Maenner MJ, Rice CE, Arneson CL, et al. Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. JAMA Psychiatry 2014;71:292–300. 10.1001/jamapsychiatry.2013.3893

Source: PubMed

3
Abonnere